296P - Patient-tailored tamoxifen dosing based on an increased quantitative understanding of its complex pharmacokinetics: A novel integrative modelling approach
Mueller-Schoell, A., Klopp-Schulze, L., Huisinga, W., Joerger, M., Neven, P., Koolen, S.L., Mathijssen, R.H.J., Schmidt, S., Kloft, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Patient-tailored tamoxifen dosing based on an increased quantitative understanding of its complex pharmacokinetics: A novel integrative modelling approach
Mueller-Schoell, A., Klopp-Schulze, L., Huisinga, W., Joerger, M., Neven, P., Koolen, S.L., Mathijssen, R.H.J., Schmidt, S., Kloft, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
296PPatient-tailored tamoxifen dosing based on an increased quantitative understanding of its complex pharmacokinetics: A novel integrative modelling approach
Mueller-Schoell, A, Klopp-Schulze, L, Huisinga, W, Joerger, M, Neven, P, Koolen, S L, Mathijssen, R H J, Schmidt, S, Kloft, C
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
575P TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumours: Dose escalation part of a multicenter open-label phase I trial (SAKK 65/16)
Hess, D., Colombo, I., Haefliger, S., Bastian, S., Rabaglio, M., Metaxas, Y., Eckhardt, K., Kopp, C., Hayoz, S., Mueller-Schoell, A., Kloft, C., Sessa, C., Stathis, A., Joerger, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article